Sydney Jennings

Global confirmed cases of COVID-19 have surpassed 115 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Which states have the highest vaccination rates? What about the lowest death rate? Results from a recent nationwide comparison on the safest states during COVID-19 shed light.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

New real-world data from England suggests that the Oxford-AstraZeneca and Pfizer-BioNTech COVID-19 vaccines are highly effective in reducing infections among older patients.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Johnson & Johnson's COVID-19 vaccine is now the third vaccine to receive emergency use authorization in the US.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new modeling study estimates that 64% of US COVID-19 hospitalizations were attributable to at least 1 of 4 pre-existing cardiometabolic conditions.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Results of a new study show that the Pfizer-BioNTech COVID-19 vaccine is 92% effective at preventing severe COVID-19 after 2 doses in over half a million study participants.

Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The FDA announced today that Johnson & Johnson's single-dose COVID-19 vaccine was found to be safe and effective against the novel disease.

Get a first look at key 8 studies to be presented at the upcoming AAAAI 2021 virtual meeting starting this Friday, February 26, 2021.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

US COVID-19 mortalities have surpassed 500 000. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

In a new survey of patients with severe asthma, COVID-19-related anxiety was found to be a potential risk factor for clinical worsening of disease and decline in quality of life.

US confirmed cases of COVID-19 have surpassed 28 million; global cases have reached 111 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Irregular sleeping patterns can increase risk of depression and lower daily mood over the long term, according to a new study of first-year medical students.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

SAMPLE: Approximately what percentage of the total US population had an STI at a given point in 2018? Plus 6 more questions on STI trends based on the latest CDC data.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new review of >60 000 patients with diabetes found CGM use during the early weeks of the COVID-19 pandemic improved their time in range.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

New research suggests obesity is responsible for 30%-53% of new type 2 diabetes cases in the US annually.

Global confirmed cases of COVID-19 have surpassed 109 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Global confirmed cases of COVID-19 have surpassed 108 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Double-masking found to reduce SARS-CoV-2 spread, FDA decision on antibody cocktail for treatment of COVID-19, and 8 more news briefs summarized for primary care.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In the first study of its kind, pre-existing eosinophilia was protective from COVID-19-related hospital admission and mortality in patients with asthma.